246 related articles for article (PubMed ID: 5313741)
1. [On ocular damage caused by chloroquine].
Rinaldi G; Coslovich E; Tuvo F
Minerva Med; 1971 Feb; 62(16):766-9. PubMed ID: 5313741
[No Abstract] [Full Text] [Related]
2. Ocular damage in chloroquine therapy.
Nylander U
Acta Ophthalmol (Copenh); 1967; ():Suppl 92:1-71. PubMed ID: 4866642
[No Abstract] [Full Text] [Related]
3. Acquired color vision defects secondary to retinal drug toxicity.
Grützner P
Ophthalmologica; 1969; 158 Suppl():592-604. PubMed ID: 5307973
[No Abstract] [Full Text] [Related]
4. [Chloroquine and ocular disorders].
Kimura R; Nagano S; Watanabe H; Okamura R
Seikei Geka; 1966 Jun; 17(6):468-73. PubMed ID: 6007161
[No Abstract] [Full Text] [Related]
5. [Results of ophthalmologic examination in 54 patients undergoing prolonged treatment with antimalarials].
David-Chaussé J; Bessière E; Vérin P; Magendie P
Rhumatologie; 1967 Jan; 19(1):17-26. PubMed ID: 6044716
[No Abstract] [Full Text] [Related]
6. Chloroquine: ophthalmological safety, and clinical assessment in rheumatoid arthritis.
Percival SP; Meanock I
Br Med J; 1968 Sep; 3(5618):579-84. PubMed ID: 4875645
[TBL] [Abstract][Full Text] [Related]
7. [Ocular side effects of chloroquine treatment of rheumatoid arthritis patients].
Glennås A; Brath HK; Bergaust B
Tidsskr Nor Laegeforen; 1980 May; 100(13):902-3. PubMed ID: 7385132
[No Abstract] [Full Text] [Related]
8. [Toxic lesions of the organ of vision caused by chloroquine derivatives].
Kolotova AI; Ermakov NV
Vestn Oftalmol; 2003; 119(1):39-42. PubMed ID: 12608045
[TBL] [Abstract][Full Text] [Related]
9. Pigmentation and retinopathy due to chloroquine.
Stewart TW; Miles DW; Earnshaw ER
Acta Derm Venereol; 1968; 48(1):47-52. PubMed ID: 4174103
[No Abstract] [Full Text] [Related]
10. [Ocular involvement in chloroquine therapy].
Godel V; Nemet P; Stein R
Harefuah; 1972 Jul; 83(2):60-3. PubMed ID: 5068910
[No Abstract] [Full Text] [Related]
11. [Eye damages induced by Myambutol (ethambutol-dihydrochloride Lederle)].
Walraph G
Z Arztl Fortbild (Jena); 1971 Jan; 65(2):103-7. PubMed ID: 5314838
[No Abstract] [Full Text] [Related]
12. [Ophthalmic side effects of chloroquine in patients with rheumatoid arthritis].
Sarmela T; Kajander A
Duodecim; 1968; 84(5):306-11. PubMed ID: 5670747
[No Abstract] [Full Text] [Related]
13. [Basic and clinical study on chloroquine therapy of rheumatic diseases. (2). Eye disorders due to chloroquine].
Sugiyama T; Okazaki T; Yabe Y; Suda H; Saito T
Saishin Igaku; 1967 Oct; 22(10):2331-5. PubMed ID: 4871487
[No Abstract] [Full Text] [Related]
14. Ocular damage in chloroquine therapy.
Nylander U
Acta Ophthalmol (Copenh); 1966; 44(3):335-48. PubMed ID: 5953229
[No Abstract] [Full Text] [Related]
15. [The changes in the electric retinal activity during resochin treatment].
Svĕrák J; Peregrin J; Salavec M
Klin Monbl Augenheilkd; 1967 Nov; 151(5):633-40. PubMed ID: 5597424
[No Abstract] [Full Text] [Related]
16. [Ophthalmologic study of patients receiving psychotropic drugs].
Gol'dovskaia IL
Zh Nevropatol Psikhiatr Im S S Korsakova; 1970 May; 70(5):759-62. PubMed ID: 5311196
[No Abstract] [Full Text] [Related]
17. Chloroquine ocular toxicity.
Bernstein HN
Surv Ophthalmol; 1967 Oct; 12(5):415-47. PubMed ID: 4980087
[No Abstract] [Full Text] [Related]
18. Detection of color vision defects in chloroquine retinopathy.
Vu BL; Easterbrook M; Hovis JK
Ophthalmology; 1999 Sep; 106(9):1799-803; discussion 1804. PubMed ID: 10485553
[TBL] [Abstract][Full Text] [Related]
19. [Research on ocular disorders appearing in ethambutol therapy].
Cernea P; Petria I; Popa V
Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1981; 25(3):209-12. PubMed ID: 6460294
[No Abstract] [Full Text] [Related]
20. Some iatrogenic ocular diseases from systemically administered drugs.
Bernstein HN
Int Ophthalmol Clin; 1970; 10(3):553-619. PubMed ID: 4933547
[No Abstract] [Full Text] [Related]
[Next] [New Search]
